Citations (51)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Claudia Andreu-Vieyra, John Lai, Benjamin P. Berman, Baruch Frenkel, Li Jia, Peter A. Jones & Gerhard A. Coetzee. (2011) Dynamic Nucleosome-Depleted Regions at Androgen Receptor Enhancers in the Absence of Ligand in Prostate Cancer Cells. Molecular and Cellular Biology 31:23, pages 4648-4662.
Read now
Read now
H. Karimi Kinyamu & Trevor K. Archer. (2007) Proteasome Activity Modulates Chromatin Modifications and RNA Polymerase II Phosphorylation To Enhance Glucocorticoid Receptor-Mediated Transcription. Molecular and Cellular Biology 27:13, pages 4891-4904.
Read now
Read now
Articles from other publishers (49)
Konsta Kukkonen, Sinja Taavitsainen, Laura Huhtala, Joonas Uusi-Makela, Kirsi J. Granberg, Matti Nykter & Alfonso Urbanucci. (2021) Chromatin and Epigenetic Dysregulation of Prostate Cancer Development, Progression, and Therapeutic Response. Cancers 13:13, pages 3325.
Crossref
Crossref
Chao chen, Yong-yuan Jian, Xiang-you Zhao, Yu-ling Liu & Qi-ke Xie. (2020) The involvement of hsa_circ_0000417 in the development of hypospadias by regulating AR. Differentiation 116, pages 9-15.
Crossref
Crossref
Peder Rustøen Braadland & Alfonso Urbanucci. (2019) Chromatin reprogramming as an adaptation mechanism in advanced prostate cancer. Endocrine-Related Cancer 26:4, pages R211-R235.
Crossref
Crossref
Saya Ito, Naruhiro Kayukawa, Takashi Ueda, Hidefumi Taniguchi, Yukako Morioka, Fumiya Hongo & Osamu Ukimura. (2018) MRGBP promotes AR-mediated transactivation of KLK3 and TMPRSS2 via acetylation of histone H2A.Z in prostate cancer cells. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 1861:9, pages 794-802.
Crossref
Crossref
Katia Ruggero, Sonia Farran-Matas, Adrian Martinez-Tebar & Alvaro Aytes. (2018) Epigenetic Regulation in Prostate Cancer Progression. Current Molecular Biology Reports 4:2, pages 101-115.
Crossref
Crossref
Bin Gui, Chen-Lin Hsieh, Philip W. Kantoff, Adam S. Kibel & Li Jia. (2017) Androgen receptor-mediated downregulation of microRNA-221 and -222 in castration-resistant prostate cancer. PLOS ONE 12:9, pages e0184166.
Crossref
Crossref
Simon Baumgart & Bernard Haendler. (2017) Exploiting Epigenetic Alterations in Prostate Cancer. International Journal of Molecular Sciences 18:5, pages 1017.
Crossref
Crossref
Indranil Chattopadhyay, Jianmin Wang, Maochun Qin, Lingqiu Gao, Renae Holtz, Robert L. Vessella, Robert W. Leach & Irwin H. Gelman. (2016) Src promotes castration-recurrent prostate cancer through androgen receptor-dependent canonical and non-canonical transcriptional signatures. Oncotarget 8:6, pages 10324-10347.
Crossref
Crossref
Vito Cucchiara, Joy Yang, Vincenzo Mirone, Allen Gao, Michael Rosenfeld & Christopher Evans. (2017) Epigenomic Regulation of Androgen Receptor Signaling: Potential Role in Prostate Cancer Therapy. Cancers 9:12, pages 9.
Crossref
Crossref
Carla M. J. Muytjens, Stella K. Vasiliou, Katerina Oikonomopoulou, Ioannis Prassas & Eleftherios P. Diamandis. (2016) Putative functions of tissue kallikrein-related peptidases in vaginal fluid. Nature Reviews Urology 13:10, pages 596-607.
Crossref
Crossref
D Zheng, B Gui, K P Gray, I Tinay, S Rafiei, Q Huang, C J Sweeney, A S Kibel & L Jia. (2016) Secretory leukocyte protease inhibitor is a survival and proliferation factor for castration-resistant prostate cancer. Oncogene 35:36, pages 4807-4815.
Crossref
Crossref
C. Svensson, J. Ceder, D. Iglesias-Gato, Y.-C. Chuan, S. T. Pang, A. Bjartell, R. M. Martinez, L. Bott, L. Helczynski, D. Ulmert, Y. Wang, Y. Niu, C. Collins & A. Flores-Morales. (2013) REST mediates androgen receptor actions on gene repression and predicts early recurrence of prostate cancer. Nucleic Acids Research 42:2, pages 999-1015.
Crossref
Crossref
Ho-Youl Lee, Eun Gyeong Yang & Hyunsung Park. (2013) Hypoxia enhances the expression of prostate-specific antigen by modifying the quantity and catalytic activity of Jumonji C domain-containing histone demethylases. Carcinogenesis 34:12, pages 2706-2715.
Crossref
Crossref
Crystal N. Marconett, Beiyun Zhou, Megan E. Rieger, Suhaida A. Selamat, Mickael Dubourd, Xiaohui Fang, Sean K. Lynch, Theresa Ryan Stueve, Kimberly D. Siegmund, Benjamin P. Berman, Zea Borok & Ite A. Laird-Offringa. (2013) Integrated Transcriptomic and Epigenomic Analysis of Primary Human Lung Epithelial Cell Differentiation. PLoS Genetics 9:6, pages e1003513.
Crossref
Crossref
Keith F. Decker, Dali Zheng, Yuhong He, Tamara Bowman, John R. Edwards & Li Jia. (2012) Persistent androgen receptor-mediated transcription in castration-resistant prostate cancer under androgen-deprived conditions. Nucleic Acids Research 40:21, pages 10765-10779.
Crossref
Crossref
Shweta Choudhry, Archana Deshpande, Liang Qiao, Kenneth Beckman, Saunak Sen & Laurence S. Baskin. (2012) Genome-wide DNA Methylation Profiling of CpG Islands in Hypospadias. Journal of Urology 188:4S, pages 1450-1456.
Crossref
Crossref
Alfonso Urbanucci, Saara Marttila, Olli A. Jänne & Tapio Visakorpi. (2012) Androgen receptor overexpression alters binding dynamics of the receptor to chromatin and chromatin structure. The Prostate 72:11, pages 1223-1232.
Crossref
Crossref
Mitchell G. Lawrence, Carson R. Stephens, Eleanor F. Need, John Lai, Grant Buchanan & Judith A. Clements. (2012) Long Terminal Repeats Act as Androgen-Responsive Enhancers for the PSA-Kallikrein Locus. Endocrinology 153:7, pages 3199-3210.
Crossref
Crossref
Maria D. Pasic, Ekaterina Olkhov, Bharati Bapat & George M. Yousef. (2012) Epigenetic regulation of kallikrein-related peptidases: there is a whole new world out there. bchm 393:5, pages 319-330.
Crossref
Crossref
Sathish Kasina & Jill A. Macoska. (2012) The CXCL12/CXCR4 axis promotes ligand-independent activation of the androgen receptor. Molecular and Cellular Endocrinology 351:2, pages 249-263.
Crossref
Crossref
Shinya Sato, Satoru Takahashi, Makoto Asamoto, Makoto Nakanishi, Toshiaki Wakita, Yuji Ogura, Yasushi Yatabe & Tomoyuki Shirai. (2012) Histone H1 expression in human prostate cancer tissues and cell lines. Pathology International 62:2, pages 84-92.
Crossref
Crossref
Harri Makkonen & Jorma J. Palvimo. (2011) Androgen receptor: acting in the three-dimensional chromatin landscape of prostate cancer cells. Hormone Molecular Biology and Clinical Investigation 5:1.
Crossref
Crossref
Mitchell G. Lawrence, John Lai & Judith A. Clements. (2010) Kallikreins on Steroids: Structure, Function, and Hormonal Regulation of Prostate-Specific Antigen and the Extended Kallikrein Locus. Endocrine Reviews 31:4, pages 407-446.
Crossref
Crossref
Jenny A. Watson, Declan J. McKenna, Perry Maxwell, James Diamond, Ken Arthur, Valerie J. McKelvey-Martin & Peter W Hamilton. (2009) Hyperacetylation in prostate cancer induces cell cycle aberrations, chromatin reorganization and altered gene expression profiles. Journal of Cellular and Molecular Medicine 14:6b, pages 1668-1682.
Crossref
Crossref
Beatrice S. Knudsen & Valera Vasioukhin. 2010.
1
50
.
Li Jia, Gilad Landan, Mark Pomerantz, Rami Jaschek, Paula Herman, David Reich, Chunli Yan, Omar Khalid, Phil Kantoff, William Oh, J. Robert Manak, Benjamin P. Berman, Brian E. Henderson, Baruch Frenkel, Christopher A. Haiman, Matthew Freedman, Amos Tanay & Gerhard A. Coetzee. (2009) Functional Enhancers at the Gene-Poor 8q24 Cancer-Linked Locus. PLoS Genetics 5:8, pages e1000597.
Crossref
Crossref
Sanjeev K. Baniwal, Omar Khalid, Donna Sir, Grant Buchanan, Gerhard A. Coetzee & Baruch Frenkel. (2009) Repression of Runx2 by Androgen Receptor (AR) in Osteoblasts and Prostate Cancer Cells: AR Binds Runx2 and Abrogates Its Recruitment to DNA. Molecular Endocrinology 23:8, pages 1203-1214.
Crossref
Crossref
Harri Makkonen, Miia Kauhanen, Ville Paakinaho, Tiina Jääskeläinen & Jorma J. Palvimo. (2009) Long-range activation of FKBP51 transcription by the androgen receptor via distal intronic enhancers. Nucleic Acids Research 37:12, pages 4135-4148.
Crossref
Crossref
June X. Zou, Linlang Guo, Alexey S. Revenko, Clifford G. Tepper, Abigael T. Gemo, Hsing-Jien Kung & Hong-Wu Chen. (2009) Androgen-Induced Coactivator ANCCA Mediates Specific Androgen Receptor Signaling in Prostate Cancer. Cancer Research 69:8, pages 3339-3346.
Crossref
Crossref
Unnati Jariwala, Jon P. Cogan, Li Jia, Baruch Frenkel & Gerhard A. Coetzee. (2009) Inhibition of AR-mediated transcription by binding of Oct1 to a motif enriched in AR-occupied regions. The Prostate 69:4, pages 392-400.
Crossref
Crossref
Derek S. Welsbie, Jin Xu, Yu Chen, Laetitia Borsu, Howard I. Scher, Neal Rosen & Charles L. Sawyers. (2009) Histone Deacetylases Are Required for Androgen Receptor Function in Hormone-Sensitive and Castrate-Resistant Prostate Cancer. Cancer Research 69:3, pages 958-966.
Crossref
Crossref
Claude Beaudoin, Sabrina Maquaire, Laurent Léotoing, Jérôme Allemand, Corinne Lours-Calet, Georges Veyssière, Michèle Manin & Laurent Morel. (2009) NPM : un nouvel acteur dans le cancer de la prostate ?. médecine/sciences 25:1, pages 19-21.
Crossref
Crossref
Li Jia, Omar Khalid, Baruch Frenkel & Gerhard A. Coetzee. 2009. Androgen Action in Prostate Cancer. Androgen Action in Prostate Cancer
405
424
.
Ping Li, Chang Tong, Ruty Mehrian-Shai, Li Jia, Nancy Wu, Youzhen Yan, Robert E. Maxson, Eric N. Schulze, Houyan Song, Chih-Lin Hsieh, Martin F. Pera & Qi-Long Ying. (2008) Germline Competent Embryonic Stem Cells Derived from Rat Blastocysts. Cell 135:7, pages 1299-1310.
Crossref
Crossref
Xu-Bao Shi, Lingru Xue, June X. Zou, Regina Gandour-Edwards, Hongwu Chen & Ralph W. deVere White. (2008) Prolonged androgen receptor loading onto chromatin and the efficient recruitment of p160 coactivators contribute to androgen-independent growth of prostate cancer cells. The Prostate 68:16, pages 1816-1826.
Crossref
Crossref
Huanjie Yang, Shalini Murthy, Fazlul H. Sarkar, Shijie Sheng, G. Prem-Veer Reddy & Q. Ping Dou. (2008) Calpain-mediated androgen receptor breakdown in apoptotic prostate cancer cells. Journal of Cellular Physiology 217:3, pages 569-576.
Crossref
Crossref
Li Jia, Benjamin P. Berman, Unnati Jariwala, Xiting Yan, Jon P. Cogan, Allison Walters, Ting Chen, Grant Buchanan, Baruch Frenkel & Gerhard A. Coetzee. (2008) Genomic Androgen Receptor-Occupied Regions with Different Functions, Defined by Histone Acetylation, Coregulators and Transcriptional Capacity. PLoS ONE 3:11, pages e3645.
Crossref
Crossref
S. Stoney SimonsJrJr. (2008) What goes on behind closed doors: physiological versus pharmacological steroid hormone actions. BioEssays 30:8, pages 744-756.
Crossref
Crossref
A. Seaton, P. Scullin, P. J. Maxwell, C. Wilson, J. Pettigrew, R. Gallagher, J. M. O'Sullivan, P. G. Johnston & D. J. J. Waugh. (2008) Interleukin-8 signaling promotes androgen-independent proliferation of prostate cancer cells via induction of androgen receptor expression and activation. Carcinogenesis 29:6, pages 1148-1156.
Crossref
Crossref
Amado J. Zurita, John F. Ward & Jeri Kim. 2008. Targeted Cancer Therapy. Targeted Cancer Therapy
289
304
.
Unnati Jariwala, Jennifer Prescott, Li Jia, Artem Barski, Steve Pregizer, Jon P Cogan, Armin Arasheben, Wayne D Tilley, Howard I Scher, William L Gerald, Grant Buchanan, Gerhard A Coetzee & Baruch Frenkel. (2007) Identification of novel androgen receptor target genes in prostate cancer. Molecular Cancer 6:1.
Crossref
Crossref
Sarah Chouinard, Olivier Barbier & Alain Bélanger. (2007) UDP-glucuronosyltransferase 2B15 (UGT2B15) and UGT2B17 Enzymes Are Major Determinants of the Androgen Response in Prostate Cancer LNCaP Cells. Journal of Biological Chemistry 282:46, pages 33466-33474.
Crossref
Crossref
Scott M. Dehm, Kevin M. Regan, Lucy J. Schmidt & Donald J. Tindall. (2007) Selective Role of an NH2-Terminal WxxLF Motif for Aberrant Androgen Receptor Activation in Androgen Depletion–Independent Prostate Cancer Cells. Cancer Research 67:20, pages 10067-10077.
Crossref
Crossref
Stephen J. Libertini, Clifford G. Tepper, Veronica Rodriguez, David M. Asmuth, Hsing-Jien Kung & Maria Mudryj. (2007) Evidence for Calpain-Mediated Androgen Receptor Cleavage as a Mechanism for Androgen Independence. Cancer Research 67:19, pages 9001-9005.
Crossref
Crossref
Jennifer Prescott, Unnati Jariwala, Li Jia, Jon P. Cogan, Artem Barski, Steve Pregizer, Howard C. Shen, Armin Arasheben, Jessica J. Neilson, Baruch Frenkel & Gerhard A. Coetzee. (2007) Androgen receptor-mediated repression of novel target genes. The Prostate 67:13, pages 1371-1383.
Crossref
Crossref
Georgios Pampalakis & Georgia Sotiropoulou. (2007) Tissue kallikrein proteolytic cascade pathways in normal physiology and cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1776:1, pages 22-31.
Crossref
Crossref
Z Nagy & L Tora. (2007) Distinct GCN5/PCAF-containing complexes function as co-activators and are involved in transcription factor and global histone acetylation. Oncogene 26:37, pages 5341-5357.
Crossref
Crossref
E Richter, S Srivastava & A Dobi. (2007) Androgen receptor and prostate cancer. Prostate Cancer and Prostatic Diseases 10:2, pages 114-118.
Crossref
Crossref
Allison H. Maffey, Toyotaka Ishibashi, Cheng He, Xiaoying Wang, Adrienne R. White, Stephen C. Hendy, Colleen C. Nelson, Paul S. Rennie & Juan Ausió. (2007) Probasin promoter assembles into a strongly positioned nucleosome that permits androgen receptor binding. Molecular and Cellular Endocrinology 268:1-2, pages 10-19.
Crossref
Crossref